Newsroom | 95569 results
Sorted by: Latest
-
Michelle Bakkedahl Joins Berkshire Hathaway HomeServices California Properties
MONARCH BEACH, Calif.--(BUSINESS WIRE)--Michelle Bakkedahl recently moved her thriving real estate business to Berkshire Hathaway HomeServices California Properties. “Michelle has a tenacious work ethic and a warm, engaging personality,” said Jeana Sander, Branch Manager and Regional Vice President for Orange County. “Along with her creative approach to marketing and commitment to help her clients develop a strategic plan that is perfectly aligned with their goals, this has made her one of our...
-
Rigaku和SPERA PHARMA建立戰略合作夥伴關係共同推進藥物開發
東京--(BUSINESS WIRE)--(美國商業資訊)-- Rigaku Holdings Corporation旗下子公司Rigaku Corporation(總部:東京昭島市;執行長:Jun Kawakami;以下簡稱「Rigaku」),與SPERA PHARMA, Inc.(總部:大阪市;董事長兼代表董事:Keitaro Iwaki;以下簡稱「SPERA PHARMA」)宣佈達成戰略合作,旨在通過整合雙方尖端技術與深厚專業知識,加速並革新藥物研發進程。 SPERA PHARMA將採用Rigaku提供的電子衍射集成平台XtaLAB Synergy-ED開展合約分析服務,為客戶的藥物研發提供強力支援。 XtaLAB Synergy-ED搭載的3D ED/MicroED1可用於物質結構分析,包括顯微晶體和微量結晶粉末。這項尖端技術具有足夠高的解析度,可以確定原子級結構,從而詳細闡明有機化合物及類似物質的分子結構。 SPERA PHARMA目前是全球醫藥行業唯一一家提供XtaLAB Synergy-ED合約分析服務的企業。Rigaku將為SPERA PHARMA的合約分析業務提供全面...
-
Rigaku和SPERA PHARMA建立战略合作伙伴关系共同推进药物开发
东京--(BUSINESS WIRE)--(美国商业资讯)-- Rigaku Holdings Corporation旗下子公司Rigaku Corporation(总部:东京昭岛市;首席执行官:Jun Kawakami;以下简称“Rigaku”),与SPERA PHARMA, Inc.(总部:大阪市;董事长兼代表董事:Keitaro Iwaki;以下简称“SPERA PHARMA”)宣布达成战略合作,旨在通过整合双方尖端技术与深厚专业知识,加速并革新药物研发进程。 SPERA PHARMA将采用Rigaku提供的电子衍射集成平台XtaLAB Synergy-ED开展合约分析服务,为客户的药物研发提供强力支持。 XtaLAB Synergy-ED搭载的3D ED/MicroED1可用于物质结构分析,包括显微晶体和微量结晶粉末。这项尖端技术具有足够高的分辨率,可以确定原子级结构,实现有机化合物和类似物质分子结构的精密阐明。 SPERA PHARMA目前是全球医药行业唯一一家提供XtaLAB Synergy-ED合约分析服务的企业。Rigaku将为SPERA PHARMA的合约分析业务提供...
-
Dun & Bradstreet to Report First Quarter 2025 Financial Results on May 1, 2025
JACKSONVILLE, Fla.--(BUSINESS WIRE)--Dun & Bradstreet Holdings, Inc. (“Dun & Bradstreet”) (NYSE:DNB), a leading global provider of business decisioning data and analytics, today announced it will report its first quarter 2025 financial results on Thursday, May 1, 2025, at approximately 7:30 a.m. Eastern Time via press release. This release will be available on Dun & Bradstreet’s Investor Relations website at https://investor.dnb.com. Due to the proposed transaction announced on Marc...
-
Pagaya Announces Timing of First Quarter 2025 Earnings Release
NEW YORK--(BUSINESS WIRE)--Pagaya Technologies (NASDAQ: PGY) intends to announce its first quarter 2025 earnings on May 7, 2025. A conference call to discuss those earnings will be held on the same day at 8:30 a.m. ET / 3:30 p.m. IDT. Details to register for the live webcast presentation will be available on Pagaya’s IR website located at investor.pagaya.com. The webcast replay will be available on the IR website following the conclusion of the event. About Pagaya Technologies Pagaya (NASDAQ: P...
-
Riassunto: Rigaku e SPERA PHARMA avviano una partnership strategica per uno sviluppo farmaceutico avanzato
TOKYO--(BUSINESS WIRE)--Rigaku Corporation, azienda del Gruppo di Rigaku Holdings Corporation (sede centrale: Akishima, Tokyo; CEO: Jun Kawakami; di seguito “Rigaku”), e SPERA PHARMA, Inc. (sede centrale: Osaka; Presidente e Direttore rappresentante: Keitaro Iwaki; di seguito “SPERA PHARMA”) hanno avviato una collaborazione strategica mirata ad accelerare e trasformare uno sviluppo farmaceutico utilizzando le tecnologie all'avanguardia e le vaste competenze delle due aziende. SPERA PHARMA utili...
-
Rigaku y SPERA PHARMA: una asociación estratégica para el desarrollo farmacéutico avanzado
TOKIO--(BUSINESS WIRE)--Rigaku Corporation, empresa del grupo Rigaku Holdings Corporation (sede central: Akishima, Tokio; gerente general: Jun Kawakami; en adelante, ''Rigaku''), y SPERA PHARMA, Inc. (sede central: Osaka; presidente y director representante: Keitaro Iwaki; en adelante, ''SPERA PHARMA'') iniciaron una asociación estratégica destinada a acelerar y transformar el desarrollo farmacéutico, aprovechando las tecnologías de vanguardia y la vasta experiencia de ambas empresas. XtaLAB Sy...
-
onsemi to Announce First Quarter Financial Results
SCOTTSDALE, Ariz.--(BUSINESS WIRE)--onsemi (Nasdaq: ON) plans to announce its financial results for the first quarter, which ended April 4, 2025, before the market opens on Monday, May 5, 2025. The company will host a conference call at 9 a.m. Eastern Time (ET) on May 5, 2025, following the release of its financial results. Investors and interested parties can access the conference call in the following manner: Webcast: A live webcast of the conference call will be available via the “Investor R...
-
Dropbox to Announce First Quarter 2025 Earnings Results
SAN FRANCISCO--(BUSINESS WIRE)--Dropbox, Inc. (NASDAQ: DBX) announced today that it will report financial results for the first quarter ended March 31, 2025 after market close on Thursday, May 8, 2025. The company will also hold a conference call on the same day at 2:00 PM PT / 5:00 PM ET to discuss its financial results with the investment community. A live webcast and replay of the conference call can be accessed from the Dropbox investor relations website at http://investors.dropbox.com. Abo...
-
Rigaku und SPERA PHARMA gehen strategische Partnerschaft zur Förderung der pharmazeutischen Entwicklung ein
TOKIO--(BUSINESS WIRE)--Die Rigaku Corporation, ein Konzernunternehmen der Rigaku Holdings Corporation (Hauptsitz: Akishima, Tokio; CEO: Jun Kawakami; im Folgenden „Rigaku“) und SPERA PHARMA, Inc. (Hauptsitz: Osaka; President & Representative Director: Keitaro Iwaki; im Folgenden „SPERA PHARMA“) haben eine strategische Partnerschaft geschlossen, um die pharmazeutische Entwicklung durch die Nutzung der hochmodernen Technologien und des umfassenden Fachwissens beider Unternehmen zu beschleuni...